EUVIMEDEUVIMED entdecken
Crossref

New 1,2,3-triazole-linked (±)-agrimonolide derivatives as anti-ulcerative colitis agents inhibiting JAK1/STAT3 pathways

Xiao Zhang, Ming-Qian Ju, Heng-Li Yang, Chun-Fei Zhang, Mao-Kui Huang, Yan-Ping Li, Chun-Ping Wan, Ze-Wei Mao

Molecular Diversity · 2025

DOI: 10.1007/s11030-025-11368-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Xiao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming, 650500, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Triazoles, Janus Kinase 1, Colitis, Ulcerative. Die Arbeit nennt 18 Literaturangaben. Gefördert von: the Scientific Research Fund Project of Yunnan Education Department, the Open Project of Key Laboratory of Dai and Yi Medicines of Yunnan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic, nonspecific inflammatory bowel disease that is very difficult to cure. In this study, we have designed and synthesized a series of new 1,2,3-triazole-linked (±)-Agrimonolide derivatives and evaluated their anti-inflammatory activities. The in vitro results demonstrated that most triazole derivatives effectively inhibited NO production, and most compounds exhibited better anti-inflammatory activity than that of (±)-Agrimonolide and positive drug Dexamethasone. The further in vivo tests indicated that 6d could inhibit the release of inflammatory mediators in the colon tissue and alleviate Ulcerative colitis by inhibiting JAK1/STAT3 pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorTriazolesJanus Kinase 1Colitis, UlcerativeAnti-Inflammatory AgentsSignal TransductionAnimalsMiceHumansStructure-Activity Relationship

Stichwörter der Autor:innen

(±)-AgrimonolideAnti-inflammatoryJAK1/STAT3Ulcerative colitis

Substanzen

STAT3 Transcription FactorTriazolesJanus Kinase 1Anti-Inflammatory Agents

Autor:innen und Institutionen

  • Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming, 650500, China.
  • School of Chinese Materia Medica, School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, 650500, China.
  • Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming, 650500, China. lyp8691@163.com.
  • School of Chinese Materia Medica, School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, 650500, China. lyp8691@163.com.
  • Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming, 650500, China. wanchunping1012@163.com.
  • School of Chinese Materia Medica, School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, 650500, China. wanchunping1012@163.com.

Förderung

  • the Scientific Research Fund Project of Yunnan Education Department
  • the Open Project of Key Laboratory of Dai and Yi Medicines of Yunnan Province

Zitieren

APA

Zhang, X., Ju, M. Q., Yang, H. L., Zhang, C. F., Huang, M. K., Li, Y. P., Wan, C. P., & Mao, Z. W. (2025). New 1,2,3-triazole-linked (±)-agrimonolide derivatives as anti-ulcerative colitis agents inhibiting JAK1/STAT3 pathways. Molecular Diversity. https://doi.org/10.1007/s11030-025-11368-3

Vancouver

Zhang X, Ju MQ, Yang HL, Zhang CF, Huang MK, Li YP, et al. New 1,2,3-triazole-linked (±)-agrimonolide derivatives as anti-ulcerative colitis agents inhibiting JAK1/STAT3 pathways. Molecular Diversity. 2025. doi:10.1007/s11030-025-11368-3

BibTeX
@article{Zhang2025,
  author = {Zhang, Xiao and Ju, Ming-Qian and Yang, Heng-Li and Zhang, Chun-Fei and Huang, Mao-Kui and Li, Yan-Ping and Wan, Chun-Ping and Mao, Ze-Wei},
  title = {New 1,2,3-triazole-linked (±)-agrimonolide derivatives as anti-ulcerative colitis agents inhibiting JAK1/STAT3 pathways},
  journal = {Molecular Diversity},
  year = {2025},
  doi = {10.1007/s11030-025-11368-3}
}
Kostenlos starten →